{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:27:06Z","timestamp":1790130426153,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bcp.2020.113912","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T22:32:23Z","timestamp":1584052343000},"page":"113912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450"],"prefix":"10.1016","volume":"177","author":[{"given":"Jana","family":"Nekvindova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Mrkvicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Zubanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Hyrslova Vaculova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Anzenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Soucek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Radova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8450-0584","authenticated-orcid":false,"given":"Ondrej","family":"Slaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Vondracek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Spicakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Bohovicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Kala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Palicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.113912_b0005","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2020.113912_b0010","article-title":"Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis","volume":"16","author":"Ghouri","year":"2017","journal-title":"J. Carcinog."},{"key":"10.1016\/j.bcp.2020.113912_b0015","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2020.113912_b0020","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2020.113912_b0025","first-page":"77","article-title":"Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis","volume":"21","author":"Fattovich","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2020.113912_b0030","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cgh.2012.08.011","article-title":"Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies","volume":"10","author":"Mair","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2020.113912_b0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.18632\/genesandcancer.190","article-title":"Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers","volume":"10","author":"Brodeur","year":"2019","journal-title":"Genes Cancer."},{"key":"10.1016\/j.bcp.2020.113912_b0045","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.3748\/wjg.v20.i26.8681","article-title":"Expression of P450 and nuclear receptors in normal and end-stage Chinese livers","volume":"20","author":"Chen","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2020.113912_b0050","doi-asserted-by":"crossref","first-page":"28612","DOI":"10.18632\/oncotarget.8704","article-title":"Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2020.113912_b0055","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/1535-7163.MCT-15-0274","article-title":"Severely impaired and dysregulated cytochrome P450 expression and activities in hepatocellular carcinoma: implications for personalized treatment in patients","volume":"14","author":"Yan","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2020.113912_b0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2020.113912_b0065","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2017 URL https:\/\/www.R-project.org\/ [accessed 2019-11-11]."},{"key":"10.1016\/j.bcp.2020.113912_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/S0076-6879(06)11008-3","article-title":"Bioconductor: an open source framework for bioinformatics and computational biology","volume":"411","author":"Reimers","year":"2006","journal-title":"Methods Enzymol."},{"issue":"7","key":"10.1016\/j.bcp.2020.113912_b0075","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bcp.2020.113912_b0080","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1214\/16-AOAS920","article-title":"Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression","volume":"10","author":"Phipson","year":"2016","journal-title":"Ann. Appl. Stat."},{"issue":"28","key":"10.1016\/j.bcp.2020.113912_b0085","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000255","article-title":"The role of cytochromes P450 and aldo-keto reductases in prognosis of breast carcinoma patients","volume":"93","author":"Hlav\u00e1\u010d","year":"2014","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.bcp.2020.113912_b0090","first-page":"56","article-title":"Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples","volume":"26","author":"Anzenbacher","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2020.113912_b0095","series-title":"Cytochrome P450 Protocols","first-page":"73","article-title":"Catalytic assays for human cytochrome P450","author":"Chang","year":"2006"},{"key":"10.1016\/j.bcp.2020.113912_b0100","series-title":"Cytochrome P450 Structure, Mechanism, and Biochemistry","first-page":"523","article-title":"Human cytochrome P450 enzymes","author":"Guengerich","year":"2015"},{"issue":"3","key":"10.1016\/j.bcp.2020.113912_b0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/sjg.SJG_290_18","article-title":"Cytochrome P450 family members are associated with fast-growing hepatocellular carcinoma and patient survival: An integrated analysis of gene expression profiles","volume":"25","author":"Liu","year":"2019","journal-title":"Saudi J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2020.113912_b0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"European association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2020.113912_b0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12072-018-9919-1","article-title":"Goals and targets for personalized therapy for HCC","volume":"13","author":"Couri","year":"2019","journal-title":"Hepatol Int."},{"issue":"8","key":"10.1016\/j.bcp.2020.113912_b0120","doi-asserted-by":"crossref","first-page":"E2367","DOI":"10.3390\/ijms19082367","article-title":"Role of cytochrome P450 enzymes in the metabolic activation of tyrosine kinase inhibitors","volume":"19","author":"Jackson","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2020.113912_b0125","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/sj.onc.1209377","article-title":"Cytochrome P450 pharmacogenetics and cancer","volume":"25","author":"Rodriguez-Antona","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bcp.2020.113912_b0130","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1124\/mol.110.067652","article-title":"Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity","volume":"78","author":"Gomez","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"36","key":"10.1016\/j.bcp.2020.113912_b0135","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.3748\/wjg.v24.i36.4152","article-title":"Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and\/or prognostic markers?","volume":"24","author":"Marisi","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2020.113912_b0140","unstructured":"Food and Drug Agency. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-ramucirumab-hepatocellular-carcinoma [accessed 2019-11-15]."},{"issue":"20","key":"10.1016\/j.bcp.2020.113912_b0145","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1158\/1078-0432.CCR-12-1967","article-title":"Ontogeny and sorafenib metabolism","volume":"18","author":"Zimmerman","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2020.113912_b0150","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/acs.chemrestox.8b00005","article-title":"Cytochromes P450 1A2 and 3A4 catalyze the metabolic activation of sunitinib","volume":"31","author":"Amaya","year":"2018","journal-title":"Chem. Res. Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2020.113912_b0155","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1124\/dmd.110.037853","article-title":"Sorafenib and sunitinib, two anticancer drugs, inhibit CYP3A4-mediated and activate CY3A5-mediated midazolam 1'-hydroxylation","volume":"39","author":"Sugiyama","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2020.113912_b0160","unstructured":"Flockhart, D.A. Drug Interactions: Cytochrome P450 Drug Interaction Table. Indiana University School of Medicine (2007). \u201chttps:\/\/drug-interactions.medicine.iu.edu\u201d Accessed [15 Nov 2019]."},{"key":"10.1016\/j.bcp.2020.113912_b0165","article-title":"Sorafenib metabolism is significantly altered in the liver tumour tissue of hepatocellular carcinoma patient","volume":"9","author":"Ye","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bcp.2020.113912_b0170","doi-asserted-by":"crossref","first-page":"G608","DOI":"10.1152\/ajpgi.00335.2018","article-title":"Hepatic CYP1A2 activity in liver tumours and the implications for preoperative volume-function analysis","volume":"316","author":"Wuensch","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2020.113912_b0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/jgh.14406","article-title":"Cytochrome P450 4A11 expression in tumour cells: A favorable prognostic factor for hepatocellular carcinoma patients","volume":"34","author":"Eun","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"31","key":"10.1016\/j.bcp.2020.113912_b0180","doi-asserted-by":"crossref","first-page":"22058","DOI":"10.18632\/oncotarget.25178","article-title":"The down-regulation of the CYP2C19 gene is associated with aggressive tumour potential and the poorer recurrence-free survival of hepatocellular carcinoma","volume":"9","author":"Ashida","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.bcp.2020.113912_b0185","doi-asserted-by":"crossref","first-page":"5859415","DOI":"10.1155\/2018\/5859415","article-title":"Downregulation of CYP2A6 and CYP2C8 in tumour tissues is linked to worse overall survival and recurrence-free survival from hepatocellular carcinoma","volume":"2018","author":"Ren","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.bcp.2020.113912_b0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cmet.2015.02.004","article-title":"A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice","volume":"21","author":"Li","year":"2015","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2020.113912_b0195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.28391","article-title":"novel long noncoding RNA Lnc-HC binds hnRNPA2B1 to regulate expressions of Cyp7a1 and Abca1 in hepatocytic cholesterol","volume":"64","author":"Lan","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2020.113912_b0200","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1124\/mol.118.112235","article-title":"A transcriptional regulatory network containing nuclear receptors and long noncoding RNAs controls basal and drug-induced expression of cytochrome P450s in HepaRG cells","volume":"94","author":"Chen","year":"2018","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2020.113912_b0205","first-page":"180","article-title":"Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis","volume":"37","author":"Li","year":"2019","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.bcp.2020.113912_b0210","article-title":"Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemoresistance","author":"Wang","year":"2019","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:12:09Z","timestamp":1757769129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220301404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":41,"alternative-id":["S0006295220301404"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113912","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113912"}}